au.\*:("WONG, F. M. P")
Results 1 to 5 of 5
Selection :
Eradication of human Non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamideKLASA, R. J; BALLY, M. B; NG, R et al.Clinical cancer research. 2000, Vol 6, Num 6, pp 2492-2500, issn 1078-0432Article
Lipid/DNA complexes as an intermediate in the preparation of particles for gene transfer: an alternative to cationic liposome/DNA aggregatesBALLY, M. B; ZHANG, Y.-P; WONG, F. M. P et al.Advanced drug delivery reviews. 1997, Vol 24, Num 2-3, pp 275-290, issn 0169-409XConference Paper
Biological barriers to cellular delivery of lipid-based DNA carriersBALLY, M. B; HARVIE, P; WONG, F. M. P et al.Advanced drug delivery reviews. 1999, Vol 38, Num 3, pp 291-315, issn 0169-409XArticle
Phosphatidylethanolamine mediated destabilization of lipid-based pDNA delivery systemsWONG, F. M. P; HARVIE, P; ZHANG, Y.-P et al.International journal of pharmaceutics. 2003, Vol 255, Num 1-2, pp 117-127, issn 0378-5173, 11 p.Article
A lipid-based delivery system for antisense oligonucleotides derived from a hydrophobic complexWONG, F. M. P; MACADAM, S. A; KIM, A et al.Journal of drug targeting. 2002, Vol 10, Num 8, pp 615-623, issn 1061-186X, 9 p.Article